CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 9 years ago You may also like 55:54 COVID-19, Social Distancing & Quarantine: Coping with Stress & Anxiety (April 8, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 33:43 Family Friday: Staying Active with Physical Therapy & Your DuchenneDaily20 5 years ago Family Friday,Webinars 58:39 COVID-19 & Adults with Duchenne (April 1, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 41:13 Family Friday: Homeschooling Hacks 5 years ago Family Friday,Webinars 1:09:09 COVID-19 & Medications: What is safe in Duchenne? (March 26, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 55:42 Family Friday: Home Schedules & School 5 years ago Family Friday,Webinars 1:06:10 COVID-19 & Duchenne: What you need to know (March 19, 2020) 5 years ago Care Webinars,COVID-19 Webinars,Webinars 51:41 Teen & Young Adult Trial Participation in Duchenne – Industry & Community Perspectives (March 4, 2020) 5 years ago Research & Clinical Trial Webinars,Webinars «1…1112131415…25»Page 13 of 25
by: Parent Project Muscular Dystrophy
